How well does NamSor perform in predicting the country of origin and ethnicity of individuals based on their first and last names?


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 03 08 2023
accepted: 02 11 2023
medline: 20 11 2023
pubmed: 17 11 2023
entrez: 16 11 2023
Statut: epublish

Résumé

We aimed to evaluate NamSor's performance in predicting the country of origin and ethnicity of individuals based on their first/last names. We retrieved the name and country of affiliation of all authors of PubMed publications in 2021, affiliated with universities in the twenty-two countries whose researchers authored ≥1,000 medical publications and whose percentage of migrants was <2.5% (N = 88,699). We estimated with NamSor their most likely "continent of origin" (Asia/Africa/Europe), "country of origin" and "ethnicity". We also examined two other variables that we created: "continent#2" ("Europe" replaced by "Europe/America/Oceania") and "country#2" ("Spain" replaced by "Spain/Hispanic American country" and "Portugal" replaced by "Portugal/Brazil"). Using "country of affiliation" as a proxy for "country of origin", we calculated for these five variables the proportion of misclassifications (= errorCodedWithoutNA) and the proportion of non-classifications (= naCoded). We repeated the analyses with a subsample consisting of all results with inference accuracy ≥50%. For the full sample and the subsample, errorCodedWithoutNA was 16.0% and 12.6% for "continent", 6.3% and 3.3% for "continent#2", 27.3% and 19.5% for "country", 19.7% and 11.4% for "country#2", and 20.2% and 14.8% for "ethnicity"; naCoded was zero and 18.0% for all variables, except for "ethnicity" (zero and 10.7%). NamSor is accurate in determining the continent of origin, especially when using the modified variable (continent#2) and/or restricting the analysis to names with accuracy ≥50%. The risk of misclassification is higher with country of origin or ethnicity, but decreases, as with continent of origin, when using the modified variable (country#2) and/or the subsample.

Sections du résumé

BACKGROUND BACKGROUND
We aimed to evaluate NamSor's performance in predicting the country of origin and ethnicity of individuals based on their first/last names.
METHODS METHODS
We retrieved the name and country of affiliation of all authors of PubMed publications in 2021, affiliated with universities in the twenty-two countries whose researchers authored ≥1,000 medical publications and whose percentage of migrants was <2.5% (N = 88,699). We estimated with NamSor their most likely "continent of origin" (Asia/Africa/Europe), "country of origin" and "ethnicity". We also examined two other variables that we created: "continent#2" ("Europe" replaced by "Europe/America/Oceania") and "country#2" ("Spain" replaced by "Spain/Hispanic American country" and "Portugal" replaced by "Portugal/Brazil"). Using "country of affiliation" as a proxy for "country of origin", we calculated for these five variables the proportion of misclassifications (= errorCodedWithoutNA) and the proportion of non-classifications (= naCoded). We repeated the analyses with a subsample consisting of all results with inference accuracy ≥50%.
RESULTS RESULTS
For the full sample and the subsample, errorCodedWithoutNA was 16.0% and 12.6% for "continent", 6.3% and 3.3% for "continent#2", 27.3% and 19.5% for "country", 19.7% and 11.4% for "country#2", and 20.2% and 14.8% for "ethnicity"; naCoded was zero and 18.0% for all variables, except for "ethnicity" (zero and 10.7%).
CONCLUSION CONCLUSIONS
NamSor is accurate in determining the continent of origin, especially when using the modified variable (continent#2) and/or restricting the analysis to names with accuracy ≥50%. The risk of misclassification is higher with country of origin or ethnicity, but decreases, as with continent of origin, when using the modified variable (country#2) and/or the subsample.

Identifiants

pubmed: 37972002
doi: 10.1371/journal.pone.0294562
pii: PONE-D-23-24627
pmc: PMC10653483
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0294562

Informations de copyright

Copyright: © 2023 Paul Sebo. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Gen Intern Med. 2023 Feb;38(3):661-666
pubmed: 35794309
BMJ Glob Health. 2019 Oct 18;4(5):e002018
pubmed: 31750004
Eur J Intern Med. 2022 Dec;106:135-137
pubmed: 35985953
BMJ Glob Health. 2021 May;6(5):
pubmed: 33986001
J Med Libr Assoc. 2022 Apr 1;110(2):205-211
pubmed: 35440899
Eur J Intern Med. 2022 Mar;97:103-105
pubmed: 34598855
N Engl J Med. 2020 Nov 26;383(22):2148-2157
pubmed: 33252871
Nat Hum Behav. 2022 Apr;6(4):478-479
pubmed: 35273356
PLoS One. 2023 Nov 16;18(11):e0294562
pubmed: 37972002
J Med Libr Assoc. 2021 Jul 01;109(3):414-421
pubmed: 34629970
PeerJ Comput Sci. 2018 Jul 16;4:e156
pubmed: 33816809
J Med Libr Assoc. 2021 Oct 01;109(4):609-612
pubmed: 34858090
J Gen Intern Med. 2022 Nov;37(15):4024-4027
pubmed: 35292910
Fam Pract. 2020 Jul 23;37(3):325-331
pubmed: 31935279
Cureus. 2021 Apr 23;13(4):e14644
pubmed: 34046277
World J Surg. 2021 Nov;45(11):3266-3277
pubmed: 34383090
BMJ Glob Health. 2022 Feb;7(2):
pubmed: 35165096

Auteurs

Paul Sebo (P)

University Institute for Primary Care (IuMFE), University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH